Evidence map›Paper›PMID 34830855›Full record

ArticleCancers2021

Low-Dose Pesticides Alter Primary Human Bone Marrow Mesenchymal Stem/Stromal Cells through ALDH2 Inhibition.

Amélie Foucault, Noémie Ravalet, Joevin Besombes, Frédéric Picou, Nathalie Gallay, Laetitia Babin, Jérôme Bourgeais, Sophie Hamard, Jorge Domenech, Pascal Loyer and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Time for Re-Evaluating the Human Carcinogenicity of Ethylenedithiocarbamate Fungicides? A Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  2. Review
  3. Neurotoxicants driving glial aging: role of astrocytic aging in non-cell autonomous neurodegeneration.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Amélie FoucaultDepartment of Biological Hematology, Tours University Hospital, 37000 Tours, France.
Noémie RavaletDepartment of Biological Hematology, Tours University Hospital, 37000 Tours, France.ORCID 0000-0001-5779-337X
Joevin BesombesDepartment of Biological Hematology, Tours University Hospital, 37000 Tours, France.
Frédéric PicouDepartment of Biological Hematology, Tours University Hospital, 37000 Tours, France.ORCID 0000-0002-2066-2146
Nathalie GallayDepartment of Biological Hematology, Tours University Hospital, 37000 Tours, France.ORCID 0000-0002-4236-4780
Laetitia BabinCNRS ERL 7001 LNOx, EA 7501, Tours University, 37000 Tours, France.
Jérôme BourgeaisDepartment of Biological Hematology, Tours University Hospital, 37000 Tours, France.
Sophie HamardCNRS ERL 7001 LNOx, EA 7501, Tours University, 37000 Tours, France.
Jorge DomenechDepartment of Biological Hematology, Tours University Hospital, 37000 Tours, France.
Pascal LoyerINSERM U1241, NuMeCan Institute, 35000 Rennes, France.ORCID 0000-0002-5656-2673
Nicolas ValletDepartment of Hematology & Cell Therapy, Tours University Hospital, 37000 Tours, France.ORCID 0000-0001-9568-3358
Julien LejeuneCNRS ERL 7001 LNOx, EA 7501, Tours University, 37000 Tours, France.
Emmanuel GyanCNRS ERL 7001 LNOx, EA 7501, Tours University, 37000 Tours, France.
Marie C BénéDepartment of Biological Hematology & CRCINA, Nantes University Hospital, 44000 Nantes, France.
François ValletteCNRS GDR 3697 Micronit "Microenvironment of Tumor Niches", 37000 Tours, France.
Christophe OlivierINSERM UMR 1232 CRCINA, 44000 Nantes, France.ORCID 0000-0002-9398-3215
Olivier HéraultDepartment of Biological Hematology, Tours University Hospital, 37000 Tours, France.
Université de Tours · FRCentre National de la Recherche Scientifique · FRFédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine · FRInserm · FR

Funding

French Canceropole Grand-Ouest 2016-PENICA project
6 · The paper itself

Abstract

(1) Background: The impact of occupational exposure to high doses of pesticides on hematologic disorders is widely studied. Yet, lifelong exposure to low doses of pesticides, and more particularly their cocktail effect, although poorly known, could also participate to the development of such hematological diseases as myelodysplastic syndrome (MDS) in elderly patients. (2) Methods: In this study, a cocktail of seven pesticides frequently present in water and food (maneb, mancozeb, iprodione, imazalil, chlorpyrifos ethyl, diazinon and dimethoate), as determined by the European Food Safety Authority, were selected. Their in vitro effects at low-doses on primary BM-MSCs from healthy volunteers were examined. (3) Results: Exposure of normal BM-MSCs to pesticides for 21 days inhibited cell proliferation and promoted DNA damage and senescence. Concomitantly, these cells presented a decrease in aldehyde dehydrogenase 2 (ALDH2: mRNA, protein and enzymatic activity) and an increase in acetaldehyde levels. Pharmacological inhibition of ALDH2 with disulfiram recapitulated the alterations induced by exposure to low doses of pesticides. Moreover, BM-MSCs capacity to support primitive hematopoiesis was significantly altered. Similar biological abnormalities were found in primary BM-MSCs derived from MDS patients. (4) Conclusions: these results suggest that ALDH2 could participate in the pathophysiology of MDS in elderly people long exposed to low doses of pesticides.

Indexed as

ALDH2hematopoiesismesenchymal stem/stromal cellsmyelodysplastic syndromepesticides

Identifiers

PMID34830855
PMCPMC8616329
OpenAlexW3214496138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.